Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 GBX | 0.00% |
|
-8.06% | +100.00% |
06-12 | EARNINGS AND TRADING: Distil loss widens; Genflow welcomes grant | AN |
05-30 | Genflow Biosciences receives 50% of grant for sarcopenia project | AN |
Sales 2022 | - | Sales 2023 | - | Capitalization | 4.17M 5.71M |
---|---|---|---|---|---|
Net income 2022 | -1M -1.37M | Net income 2023 | -1M -1.37M | EV / Sales 2022 | - |
Net cash position 2022 | 2.36M 3.23M | Net cash position 2023 | 684K 937K | EV / Sales 2023 | - |
P/E ratio 2022 |
-5.26
x | P/E ratio 2023 |
-2.56
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 36.13% |
1 week | -8.06% | ||
Current month | -6.56% | ||
1 month | +26.67% | ||
3 months | +93.22% | ||
6 months | +103.57% | ||
Current year | +100.00% |
![Extreme 2.8](/images/extremecours_fleche.png)
![Extreme 2.3](/images/extremecours_fleche.png)
![Extreme 1.3225](/images/extremecours_fleche.png)
![Extreme 1.3225](/images/extremecours_fleche.png)
![Extreme 1.3225](/images/extremecours_fleche.png)
![Extreme 1.3225](/images/extremecours_fleche.png)
![Extreme 1.3225](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 22-06-28 | |
Tamara Joseph
CHM | Chairman | 61 | 22-06-28 |
Founder | 66 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 2.85 | 0.00% | 5,587 |
24-06-20 | 2.85 | -1.72% | 20,189 |
24-06-19 | 2.9 | -3.33% | 2,237,229 |
24-06-18 | 3 | -1.64% | 201,337 |
24-06-17 | 3.05 | -1.61% | 446,454 |
Delayed Quote London S.E., June 21, 2024 at 11:35 am
More quotes1st Jan change | Capi. | |
---|---|---|
+100.00% | 12.58M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- GENF Stock